Form 4: Bioventus Inc. Executive Anthony D'Adamio Reports Acquisition of Restricted Stock Units and Stock Options

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., reports the acquisition of restricted stock units and stock options.

Summary

• On March 15, 2024, Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., reported the acquisition of 51,920 restricted stock units (RSUs) and 34,696 RSUs, each representing a contingent right to receive one share of Class A common stock.
• D'Adamio also acquired stock options for 120,000 shares of Class A Common Stock at an exercise price of $5.45, expiring on March 15, 2034.
• The 51,920 RSUs and the stock options vest in four equal installments on the anniversaries of February 15, 2024, subject to continued service.
• The 34,696 RSUs vest on June 15, 2024, also subject to continued service.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of insider transactions, which is neither particularly positive nor negative. The acquisition of shares by an executive can be seen as a mildly positive signal.

Positives

• The acquisition of RSUs and stock options suggests confidence in the company's future performance from a key executive.

Future Outlook

The vesting of the RSUs and options is contingent upon continued service, aligning executive compensation with long-term company performance.

Industry Context

Form 4 filings are standard disclosures for corporate insiders, providing transparency into their transactions in the company's securities.

Stakeholder Impact

• The acquisition of shares by a key executive could be viewed positively by shareholders.

Key Dates